BioCentury
ARTICLE | Distillery Therapeutics

Neurology

March 7, 2018 7:12 PM UTC

Cell culture studies suggest inhibiting TMX2 could help treat ALS caused by hexanucleotide repeat expansions in C9orf72. In a screen of a human acute myelogenous leukemia (AML) cell line and primary m...